RIPK1 and colorectal carcinoma: To assess the potential clinical significance of this finding, we performed IHC using a human CRC tissue microarray (TMA; CDA3) consisting of primary CRC tissues (n = 38) and normal colorectal tissues (n = 9) to determine the expression patterns of RIP1 and β-catenin (Fig. 1D).